Bhattacharyya Neil
Division of Otolaryngology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Otolaryngol Head Neck Surg. 2005 Aug;133(2):173-7. doi: 10.1016/j.otohns.2005.03.082.
To determine whether patients with chronic rhinosinusitis (CRS) exhibit more severe sinonasal symptom scores as compared with patients with nasal septal deviation (NSD) alone.
Two patient cohorts were prospectively identified: patients undergoing surgery for NSD alone and those undergoing endoscopic sinus surgery for CRS without NSD. Patients in the NSD group were required to have normal paranasal sinus CT scans, whereas patients in the CRS group were required to have radiographic evidence of CRS. All patients completed the Rhinosinusitis Symptom Inventory (RSI). Statistical comparisons were conducted between cohorts with respect to RSI symptom domains and medical resource utilization.
A total of 42 patients were identified in the NSD group (mean age, 40.8 years) and 155 patients were identified in the CRS group (mean age, 44.9). Patients with CRS demonstrated higher severity scores for the nasal symptom domains (60.3 [CRS] versus 53.9 [NSD], P = 0.037). Oropharyngeal symptoms and total symptoms were also worse for the CRS group versus the NSD group (29.8 versus 23.1, P = 0.014 and 43.0 versus 37.0, P = 0.030). Facial and systemic symptom scores did not differ between groups. Patients with CRS demonstrated significantly higher utilization rates for topical nasal steroids (21.2 versus 12.2 weeks, P = 0.006) and oral antibiotics (7.9 weeks versus 2.1 weeks, P < 0.001), but not for oral antihistamines (P = 0.420).
Although patients with CRS manifest higher sinonasal symptom scores than patients with NSD alone, differentiating these 2 diagnoses on the basis of symptoms alone is difficult. These data suggest that as a disease process, CRS confers a significant disease burden with more significant negative symptom impact.
确定与单纯鼻中隔偏曲(NSD)患者相比,慢性鼻-鼻窦炎(CRS)患者的鼻窦症状评分是否更严重。
前瞻性纳入两个患者队列:仅接受NSD手术的患者和接受无NSD的CRS内镜鼻窦手术的患者。NSD组患者要求鼻窦CT扫描正常,而CRS组患者要求有CRS的影像学证据。所有患者均完成鼻-鼻窦炎症状量表(RSI)。对队列间RSI症状领域和医疗资源利用情况进行统计学比较。
NSD组共纳入42例患者(平均年龄40.8岁),CRS组共纳入155例患者(平均年龄44.9岁)。CRS患者的鼻部症状领域严重程度评分更高(60.3[CRS]对53.9[NSD],P = 0.037)。CRS组的口咽症状和总症状也比NSD组更严重(29.8对23.1,P = 0.014;43.0对37.0,P = 0.030)。两组间面部和全身症状评分无差异。CRS患者局部鼻用类固醇的使用率显著更高(21.2周对12.2周,P = 0.006),口服抗生素的使用率也显著更高(7.9周对2.1周,P < 0.001),但口服抗组胺药的使用率无差异(P = 0.420)。
尽管CRS患者的鼻窦症状评分高于单纯NSD患者,但仅根据症状区分这两种诊断很困难。这些数据表明,作为一种疾病过程,CRS带来了重大的疾病负担,对负面症状的影响更大。